Dow rises for a fourth day, gains more than 100 points after J&J vaccine deal and Disney earnings

Dow rises for a fourth day, gains more than 100 points after J&J vaccine deal and Disney earnings
This is a developing news story. Please check back for updates:
https://www.cnbc.com/2020/08/04/stock-futures-flat-as-investors-await-stimulus-bill.html

Private payrolls grow by 167,000 in July, well below expectations


Inbox
x




CNBC Breaking News <breakingnews@response.cnbc.com> Unsubscribe
8:16 AM (1 hour ago)



to me







CNBC | Breaking News
Private payrolls grow by 167,000 in July, well below expectations

This is a developing news story. Please check back for updates:

https://www.cnbc.com/2020/08/05/adp-private-payroll-growth-at-167000-in-july-well-below-expectations.html




Follow @CNBCnow for breaking news and real-time market updates




Novavax up 17% on early-stage COVID-19 vaccine data
Aug. 5, 2020 6:52 AM ET|About: Novavax, Inc. (NVAX)|By: Douglas W. House, SA News Editor 
In a significant turnaround, Novavax (NASDAQ:NVAX) is up 17% 
premarket on light volume on the heels of positive Phase 1 data on COVID-19 vaccine candidate NVX-CoV2373.
Neutralizing antibody titers were induced in all participants and the safety profile was favorable.
Shares were volatile after the close yesterday when STAT News initially reported that eight subjects were hospitalized. Shares sold off ~30% then reversed when STAT corrected its story stating that the company informed it that there were no hospitalizations.
Selected COVID-19 vaccine players: AstraZeneca (NYSE:AZN) (+2%
); GlaxoSmithKline (NYSE:GSK) (+1%
); Pfizer (NYSE:PFE) (+1%
); BioNTech (NASDAQ:BNTX) (+1%
); Moderna (NASDAQ:MRNA) (+2%
), Inovio Pharmaceuticals (NASDAQ:INO) (+2%
); iBio (NYSEMKT:IBIO) (+2%)
See all stocks on the move »

8,008 people get NVAX breaking news and analysis by email alert
Get email alerts on NVAX




Recommended for you:

Why Novavax Is Outperforming Moderna (NASDAQ:NVAX)
Chris Lau



The Big Tax Shift
Lyn Alden Schwartzer


Apple: Say Goodbye To $400 (NASDAQ:AAPL)
BOOX Research


Sorrento’s 158% Spike Was Just The Beginning (NASDAQ:SRNE)
John Reilly


Retirement Strategy: Say Hello To My Little Old Friend – Annaly (NYSE:NLY)
Regarded Solutions

From other sites
Stocks making the biggest moves after hours: Nikola, Twilio, Novavax and more Video at CNBC.com (Tue, 5:56PM)
Novavax’s coronavirus vaccine generates promising immune response in early trial, data shows Video at CNBC.com (Tue, 5:48PM)
President Trump announces $265 million award to Fujifilm for coronavirus vaccine manufacturing Video at CNBC.com (Jul 27, 2020)
Stock futures flat following sell-off on Wall Street Video at CNBC.com (Jul 7, 2020)
Stocks making the biggest moves midday: Novavax, Shake Shack, Tesla, Apple & more Video at CNBC.com (Jul 7, 2020)
Comments 16
 • Sort by    Newest
   Oldest
   Most liked 
Newest


Add Your Comment


Publish


Dont Tread on Me
Comments1058 | + Follow
The market is the master and the only determinant that matters when parsing data and liquifying share price.
05 Aug 2020, 09:43 AMReply0Like

jevypopiPremium
Comments195 | + Follow
I just don’t see how it translates into $. The government has funded the research – what do you think Congress does to limit drug price? Other countries won’t pay up. Chinese will steal the recipe. What is the actual cost to get the drug out, what will they be allowed to charge, and what is left for investors at the end of the day. And BTW why is insider ownership so low?
05 Aug 2020, 09:36 AMReply0Like

jevypopiPremium
Comments195 | + Follow
Anybody seen the Ladenburg Thalmen report just out which downgrades NVAX to sell?
05 Aug 2020, 09:30 AMReply0Like

14278212
Comments20 | + Follow
The article on Medrxiv cannot be found. Every news outlet references an article on that pre-print server but if you look for Gregory Glenn, Gregory M. Glenn, or Novavax as authors, there is no new study. There is a post from May 2020 relating to another vaccine.This seems to be a fake announcement and should be treated with caution. It is unclear why nobody around has posted a link to the supposedly submitted article. Billion-dollar valuation, weak presentation of data, announcing new data, and showing old data from baboons and mice the other day, only to make the stock swing wildly to their favor. Odd but well-working attempt in mass psychology !!!
05 Aug 2020, 09:22 AMReply0Like

HardytheTraderPRO
Comments711 | + Follow
Yeah makes total sense. Value $NVAX and a couple of other companies at billions, some like $BNTX even double digit billions based on a potential drug for COVID-19. This won’t end well. My only hope is that the big bang will benefit the rest of the market
05 Aug 2020, 09:14 AMReply0Like

mastma0321
Comments124 | + Follow
All of these COVID-19 stocks are going to crater when an actual vaccine does get approval. I realize that Novavax has other drugs in its pipeline, but this valuation is beyond ridiculous.
05 Aug 2020, 08:48 AMReply5Like

Buzz Stockyear
Comments84 | + Follow
I don’t understand how this stock goes up wildly. The company does have a bad history, but their promising drugs could change its perception and maybe be bought out by a big company like Merck.
05 Aug 2020, 08:48 AMReply0Like

JohnCraft
Comments472 | + Follow
All r bubbles
05 Aug 2020, 08:37 AMReply1Like

zagman
Comments221 | + Follow
SA, What happened to the interactive symbols showing price and description?
05 Aug 2020, 08:16 AMReply0Like

Pisces19081
Comments1837 | + Follow
NVAX was high like this one time before a long time ago and dropped like a ROCK and killed a lot of small time investors. Check pass scale.
05 Aug 2020, 07:26 AMReply2Like

halba12
Comments363 | + Follow
no. simply ridiculous.
05 Aug 2020, 07:10 AMReply2Like

Bogie 1
Comments330 | + Follow
so more fake news caused people to lose money by dumping shares only to see massive rebound. well here come the lawsuits, this is a good reason not to trade in the after hours, at least the vaccine news was positive from a company I still don’t trust
05 Aug 2020, 06:59 AMReply2Like

VicHut
Comments2 | + Follow
@Bogie 1 why you don’t trust NVAX? I don’t have this stock though..just curious. Thanks
05 Aug 2020, 07:18 AMReply0Like

Gauranga14344
Comments227 | + Follow
In so many years they never were able to bring one product to the market.Now with all the rushing and corners being cut, this might be their one and only chance.
05 Aug 2020, 07:24 AMReply2Like

Biocall
Comments36 | + Follow
Why people keep forgetting nanoflu? P3 positive way better than competitors on market product. Approval is just a matter of time.
05 Aug 2020, 07:58 AMReply1Like

djsreds
Comments74 | + Follow
Does Jim Willbanks still post here? Would like to hear his thoughts.
05 Aug 2020, 06:57 AMReply1Like











































































RSS Feeds|
Advertise with Us|
Sitemap|
About Us|
Feedback|
Careers|
Contact Us
Terms of Use|
Privacy|
Market Data Disclaimer|
© 2020 Seeking Alpha

You are not logged in.
Create a free account and get customized news,
alerts, and analysis about the stocks you follow.
Already have an account?Sign in
Email Address
 
 

I agree toTerms of Use&Privacy Policy.


























Unsubscribe
Manage Newsletters
Terms of Service
Join the CNBC Panel
 
Digital Products
Feedback
Privacy Policy
CNBC Events
 
© 2020 CNBC LLC. All rights reserved. A property of NBCUniversal.
900 Sylvan Avenue, Englewood Cliffs, NJ 07632
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis.
Data also provided by THOMSON REUTERS






ReplyForward













Social media & sharing icons powered by UltimatelySocial
error

Enjoy this blog? Please spread the word :)

RSS
Follow by Email
LinkedIn
LinkedIn
Share
Scroll to Top